A new groundbreaking study showed that a common cholesterol-lowering blood pressure medication could slow cognitive decline in Alzheimer's patients.
Swedish researchers, who conducted the study based on data from the Swedish Registry for Cognitive/Dementia Disorders, studied the effects of statins, drugs that reduce cholesterol, including in the brain.
The answer lies in statin ability to reduce congestion in blood pathways in the brain that can become filled with proteins, lipids like cholesterols or the beta amyloid amino acid that has recently been linked to Alzheimer's.
When blood pathways get clogged, they can kill off brain cells. The National Institute on Aging states: "Abnormal levels of this naturally occurring protein clump together to form plaques that collect between neurons and disrupt cell function." And when cell function is disrupted, a person's cognitive ability can be drastically reduced. Just a thought.
No comments:
Post a Comment